HIGHLIGHTS
- who: Teruhiko Imamura and colleagues from the Second Department of Medicine, University of Toyama, Toyama, Japan have published the research: Impact of Sodium Zirconium Cyclosilicate Therapy Cessation in Patients with Systolic Heart Failure, in the Journal: (JOURNAL)
- what: The authors aimed to investigate the impact of SZC cessation on the recurrence of hyperkalemia. As a result, patients in this study had less evidence of reverse remodeling following SZC cessation.
- future: Although further prospective randomized-control studies are warranted to clarify robust causalities among those who receive SZC for longer durations it would be . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.